Our Drug Development Division does team up with different stakeholders focused on curing these diseases. We collaborate with pharmaceutical companies, manufacturing companies, patient associations, academic researchers, and any organization interested in helping our patients have a better quality of life, and to cure them, ultimately.

Sometimes, we have helped patient associations to develop R&D projects to try new molecular targets, repurposing an existing drug, or managing some particularly difficult symptoms. We are always open and willing to hear anybody aligned with our focus and reaching them with any idea or collaboration proposal we might have.